Pages that link to "Q55670934"
Jump to navigation
Jump to search
The following pages link to Point mutations in the c-Myc transactivation domain are common in Burkitt's lymphoma and mouse plasmacytomas (Q55670934):
Displaying 50 items.
- Burkitt lymphoma (Q1016605) (← links)
- A structure-based model of the c-Myc/Bin1 protein interaction shows alternative splicing of Bin1 and c-Myc phosphorylation are key binding determinants (Q24306542) (← links)
- BIN1 is a novel MYC-interacting protein with features of a tumour suppressor (Q24318855) (← links)
- Rapamycin potentiates transforming growth factor beta-induced growth arrest in nontransformed, oncogene-transformed, and human cancer cells (Q24538036) (← links)
- Noninvasive molecular imaging of c-Myc activation in living mice (Q24613516) (← links)
- The N-Terminal Domain of c-Myc Associates with α-Tubulin and Microtubules In Vivo and In Vitro (Q24651264) (← links)
- Small-molecule inhibitors of the Myc oncoprotein (Q27025648) (← links)
- Global Phosphoproteomic Mapping of Early Mitotic Exit in Human Cells Identifies Novel Substrate Dephosphorylation Motifs (Q27311643) (← links)
- Regulation of c-Myc through phosphorylation at Ser-62 and Ser-71 by c-Jun N-terminal kinase (Q28146223) (← links)
- Function and regulation of the transcription factors of the Myc/Max/Mad network (Q28198743) (← links)
- The proto-oncogene c-myc in hematopoietic development and leukemogenesis (Q28200929) (← links)
- c-Myc recruits P-TEFb for transcription, cellular proliferation and apoptosis (Q28204153) (← links)
- c-Myc Is Glycosylated at Threonine 58, a Known Phosphorylation Site and a Mutational Hot Spot in Lymphomas (Q28295580) (← links)
- Deregulation of F-box proteins and its consequence on cancer development, progression and metastasis (Q30278581) (← links)
- c-myc overexpression activates alternative pathways for intracellular proteolysis in lymphoma cells. (Q32084062) (← links)
- A TRAIL receptor-dependent synthetic lethal relationship between MYC activation and GSK3beta/FBW7 loss of function (Q33224746) (← links)
- Immortalization of human neural stem cells with the c-myc mutant T58A. (Q33374007) (← links)
- New Myc-interacting proteins: a second Myc network emerges (Q33667300) (← links)
- MYC oncogenes and human neoplastic disease (Q33667340) (← links)
- MYC and the control of apoptosis (Q33790668) (← links)
- How cells use proteolysis to control their growth. (Q33833006) (← links)
- MYC Deregulation in Primary Human Cancers. (Q33836755) (← links)
- Destruction of Myc by ubiquitin-mediated proteolysis: cancer-associated and transforming mutations stabilize Myc. (Q33890400) (← links)
- c-Myc target genes involved in cell growth, apoptosis, and metabolism (Q33956988) (← links)
- c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cells (Q33962550) (← links)
- The c-Myc transactivation domain is a direct modulator of apoptotic versus proliferative signals (Q33963949) (← links)
- Disruption of Myc-tubulin interaction by hyperphosphorylation of c-Myc during mitosis or by constitutive hyperphosphorylation of mutant c-Myc in Burkitt's lymphoma (Q33964663) (← links)
- Induction of cell cycle progression and acceleration of apoptosis are two separable functions of c-Myc: transrepression correlates with acceleration of apoptosis (Q33965061) (← links)
- Rapid generation of human B-cell lymphomas via combined expression of Myc and Bcl2 and their use as a preclinical model for biological therapies (Q33980435) (← links)
- Myc proteins as therapeutic targets (Q33997741) (← links)
- Pathology of lymphoma in HIV. (Q34020069) (← links)
- How do viruses trick B cells into becoming lymphomas? (Q34020096) (← links)
- Interleukin-6 and interleukin-10 gene promoter polymorphisms and risk of endemic Burkitt lymphoma (Q34138588) (← links)
- Transcription factors and translocations in lymphoid and myeloid leukemia (Q34173877) (← links)
- Myc and mammary cancer: Myc is a downstream effector of the ErbB2 receptor tyrosine kinase (Q34316140) (← links)
- Therapeutic Targeting of Myc. (Q34373258) (← links)
- GSK3 takes centre stage more than 20 years after its discovery (Q34374129) (← links)
- Translocations involving c-myc and c-myc function (Q34405431) (← links)
- Functional analysis of the AUG- and CUG-initiated forms of the c-Myc protein (Q34442961) (← links)
- Expression profiling of rectal tumors defines response to neoadjuvant treatment related genes. (Q34473018) (← links)
- Tumor suppression by the Fbw7 ubiquitin ligase: mechanisms and opportunities (Q34488856) (← links)
- CRY2 and FBXL3 Cooperatively Degrade c-MYC. (Q34544579) (← links)
- The myc oncogene: MarvelouslY Complex (Q34555987) (← links)
- Kaposi sarcoma-associated herpesvirus-encoded viral FLICE inhibitory protein (vFLIP) K13 cooperates with Myc to promote lymphoma in mice (Q34616590) (← links)
- MYC phosphorylation, activation, and tumorigenic potential in hepatocellular carcinoma are regulated by HMG-CoA reductase (Q34687185) (← links)
- A conserved Myc protein domain, MBIV, regulates DNA binding, apoptosis, transformation, and G2 arrest. (Q34718058) (← links)
- Cell kinetics and cell cycle regulation in lymphomas (Q34795916) (← links)
- The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation (Q34835596) (← links)
- Intracellular glycosylation and development (Q34989577) (← links)
- Targeting c-MYC with T-cells (Q35018846) (← links)